Genomic & Biopharma NewsSalt Could Play a Role in Allergies
High salt concentrations are present in the affected skin of people with atopic dermatitis and promote the differentiation of the T helper cells involved in the development of allergic diseases.
|The Scientist, 2019-02-20 14:00:56|
Gov unveils launch of NHSX for digital, data and tech
The government has announced plans to create a new joint organisation for digital, data and technology, to be called NHSX.
|PharmaTimes, 2019-02-20 13:36:39|
Last chance to get your entry in for the 2019 Clinical Researcher of the Year – The Americas competition
This established, challenging, and free-to-enter competition will close for entry on the 25th February – don’t miss out on this great personal development opportunity.
|PharmaTimes, 2019-02-20 13:33:05|
FDA Priority Review for Roche’s entrectinib in cancer treatment
Roche has announced that the FDA has granted Priority Review for entrectinib as a treatment for NTRK fusion-positive, locally advanced or metastatic solid tumours, and to treat metastatic ROS1-positive non-small-cell lung cancer.
|PharmaTimes, 2019-02-20 13:30:55|
Keytruda falls short in late-stage liver cancer trial
MSD's anti-PD-1 therapy Keytruda did not meet its co-primary endpoints in the Phase III KEYNOTE-240 trial involving patients with liver cancer.
|PharmaTimes, 2019-02-20 13:27:06|
Study shows therapeutic potential of VEGF-A mRNA for regenerative angiogenesis in humans
An international team of researchers from academia and the biopharma industry has published a Phase 1a/b study, showing the therapeutic potential of mRNA encoding for vascular endothelial growth factor A (VEGF-A) for regenerative angiogenesis in humans.
|News Medical Life Sciences, 2019-02-20 13:07:19|
Electronic Sun Sentinel: Gene analysis lab moves to Deerfield Beach
|ORB Company News, 2016-12-02 21:24:27|
Palm Beach Post: ORB Leaves Palm Beach County for New Lab Space
David Willoughby lives in Palm Beach Gardens and, until recently, worked there too. But the owner of Ocean Ridge Biosciences wanted to expand, and he couldn't find suitable space in northern Palm Beach County.
|ORB Company News, 2016-12-02 15:35:33|
First subject dosed in endocrine disorders trial
Sosei has announced that the first subject has been dosed in a UK-based Phase I study of HTL0030310.
|PharmaTimes, 2019-02-20 13:07:19|
Nature Retracts Paper on Delivery System for CAR T Immunotherapy
The manuscript had amassed more than 50 comments about problematic figures and data on PubPeer.
|The Scientist, 2019-02-20 13:00:42|
Pfizer’s biosimilar Zirabev wins EU approval
Pfizer has announced European approval of its Avastin biosimilar Zirabev.
|PharmaTimes, 2019-02-20 12:55:08|